Janssen Announces Investigational CAR-T Therapy JNJ-68284528 Granted PRIME Designation by the European Medicines Agency
Source: Johnson and Johnson - Category: Pharmaceuticals Source Type: news
More News: European Medicines Agency (EMA) | Pharmaceuticals